A012790 Stock Overview
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 1/6 |
Sinil Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩7,360.00 |
52 Week High | ₩8,660.00 |
52 Week Low | ₩6,280.00 |
Beta | 1.52 |
1 Month Change | 7.60% |
3 Month Change | -4.54% |
1 Year Change | -10.35% |
3 Year Change | -42.03% |
5 Year Change | 9.84% |
Change since IPO | 580.76% |
Recent News & Updates
Recent updates
Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials Driving The Negative Sentiment?
Mar 11Is Sinil Pharmaceutical's (KOSDAQ:012790) 122% Share Price Increase Well Justified?
Feb 13Could The Sinil Pharmaceutical Co., Ltd. (KOSDAQ:012790) Ownership Structure Tell Us Something Useful?
Jan 17Sinil Pharmaceutical's (KOSDAQ:012790) Earnings Are Growing But Is There More To The Story?
Dec 22Are Sinil Pharmaceutical Co., Ltd.'s (KOSDAQ:012790) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Nov 26Shareholder Returns
A012790 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 1.1% | 4.3% | 2.4% |
1Y | -10.4% | 28.2% | 12.2% |
Return vs Industry: A012790 underperformed the KR Pharmaceuticals industry which returned 28.2% over the past year.
Return vs Market: A012790 underperformed the KR Market which returned 12.2% over the past year.
Price Volatility
A012790 volatility | |
---|---|
A012790 Average Weekly Movement | 3.0% |
Pharmaceuticals Industry Average Movement | 4.9% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A012790 has not had significant price volatility in the past 3 months.
Volatility Over Time: A012790's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1971 | n/a | Mi-Keun Jung | https://www.sinilpharm.com |
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services.
Sinil Pharmaceutical Co., Ltd. Fundamentals Summary
A012790 fundamental statistics | |
---|---|
Market cap | ₩83.73b |
Earnings (TTM) | ₩13.64b |
Revenue (TTM) | ₩89.14b |
6.1x
P/E Ratio0.9x
P/S RatioIs A012790 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A012790 income statement (TTM) | |
---|---|
Revenue | ₩89.14b |
Cost of Revenue | ₩51.56b |
Gross Profit | ₩37.57b |
Other Expenses | ₩23.93b |
Earnings | ₩13.64b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 1.20k |
Gross Margin | 42.15% |
Net Profit Margin | 15.30% |
Debt/Equity Ratio | 0% |
How did A012790 perform over the long term?
See historical performance and comparison